IMPACT OF EVEROLIMUS ON PERICARDIAL AND PLEURAL EFFUSIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS

被引：0
|
作者：
Barten, M.
Zuckermann, A. [1 ]
Arizon, J. M.
Dong, G. [2 ]
Eisen, H.
Kobashigawa, J.
Lehmkuhl, H. B.
Pellegrini, C.
Ross, H.
机构：
[1] Univ Vienna, Vienna, Austria
[2] Novartis Pharmaceut, E Hanover, Vietnam
来源：
TRANSPLANT INTERNATIONAL | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
0059
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [21] SURGICAL WOUND COMPLICATIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS TREATED WITH EVEROLIMUS: INCIDENCE AND MANAGEMENT
    Barten, M.
    Arizon, J. M.
    Dong, G.
    Eisen, H.
    Kobashigawa, J.
    Lehmkuhl, H. B.
    Pellegrini, C.
    Ross, H.
    Zuckermann, A.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 64 - 65
  • [22] Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
    Bergh, Niklas
    Gude, Einar
    Bartfay, Sven-Erik
    Andreassen, Arne
    Arora, Satish
    Dahlberg, Pia
    Dellgren, Goran
    Gullestad, Lars
    Gustafsson, Finn
    Karasson, Kristjan
    Radegran, Goran
    Bollano, Entela
    Andersson, Bert
    [J]. ESC HEART FAILURE, 2020, 7 (02): : 567 - 576
  • [23] Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients
    Lehmkuhl, Hans B.
    Arizon, Jose
    Vigano, Mario
    Almenar, Luis
    Gerosa, Gino
    Maccherini, Massimo
    Varnous, Shaida
    Musumeci, Francesco
    Hexham, J. Mark
    Mange, Kevin C.
    Livi, Ugolino
    [J]. TRANSPLANTATION, 2009, 88 (01) : 115 - 122
  • [24] FACTORS AFFECTING SURVIVAL OF DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS WITH THYMOGLOBULIN INDUCTION
    Zuckermann, A.
    Pellegrini, C.
    Arizon, J. M.
    Favoloro, R.
    Jiang, H.
    Cornu-Artis, C.
    Lopez, P.
    Wang, S. -S.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 67 - 67
  • [25] Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART
    Potena, L.
    Barberini, F.
    Boffini, M.
    Amarelli, C.
    Pellegrini, C.
    Livi, U.
    Masciocco, G.
    Faggian, G.
    Gerosa, G.
    Lilla, P.
    Marraudino, N.
    Porcu, M.
    Guarisco, R.
    Maccherini, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S136 - S136
  • [26] Exposure to CsA, and not to everolimus, is associated with impaired renal function in de novo heart transplant recipients.
    Varnous, Shaida
    Livi, Ugolino
    Poncelet, Alain
    Delgado, Juan
    Vermes, Emmanuelle
    Li, Yulan
    Arizon, Jose
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 346 - 346
  • [27] Everolimus Treatment Reduces the Need for Anti-CMV Prophylaxis in De Novo Heart Transplant Recipients
    Potena, L.
    Bianchi, I. G.
    D'Agostino, C.
    Abate, D.
    Magnani, G.
    Chiereghin, A.
    Grigioni, F.
    Gambino, A.
    Toscano, G.
    Sgarabotto, D.
    Gerosa, G.
    Branzi, A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S64 - S64
  • [28] Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now?
    Zuckermann, Andreas
    Wang, Shoei-Shen
    Epailly, Eric
    Barten, Markus J.
    Sigurdardottir, Vilborg
    Segovia, Javier
    Varnous, Shaida
    Turazza, Fabio M.
    Potena, Luciano
    Lehmkuhl, Hans B.
    [J]. TRANSPLANTATION REVIEWS, 2013, 27 (03) : 76 - 84
  • [29] De Novo Use of Everolimus With Elimination or Minimization of Cyclosporine in Renal Transplant Recipients
    Novoa, P. A.
    Grinyo, J. M.
    Ramos, F. J. P.
    Errasti, P.
    Franco, A.
    Aldana, G.
    Pefaur, J.
    Marti-Cuadros, A. M.
    Otero, A. B.
    Saval, N.
    Oppenheimer, F.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (09) : 3331 - 3339
  • [30] PHARMACOKINETICS OF EVEROLIMUS WHEN COMBINED WITH TACROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Rostaing, L.
    Pascual, J.
    Machein, U.
    Kovarik, J. M.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 253 - 253
12345